The Directors of Pacific One Medical – Craig Newton and Michael Stafford – have over 50 years of combined experience in these sectors with activity in Australia, Asia, North America, Europe, the Middle East and Central America.
Craig Newton is a Business Executive with 30 years’ experience in the Healthcare industry, notably in the Medical Device, Pharmaceutical and Biotech sectors, with activity in Australasia, Asia and Europe. His tertiary and post-graduate qualifications cover Science and Business, including an executive program at Babson College, Boston. Experience encompasses diverse therapeutic areas, including cardiovascular disease oncology, haematology, cell therapies, fertility and immunology. Organizations have included CSL, Serono UK, CSIRO, Bio Nova International, AVAX Australia and Cryptome Pharmaceuticals, with roles of “Chief Operating Officer”, “Sales and Marketing Director” and “Business Unit Manager”. At Serono in the UK, as Head of the Reproductive Health Division, he ran a $50m business, growing market share in the face of intense low-cost competition. As Head of Sales and Marketing at Bio Nova International, he grew the international sales and industry profile leading to the company’s successful acquisition by a major US player.
Michael Stafford is a highly-credentialed Business Manager and Consultant with over 25 years’ experience in the healthcare industry in Australia, Asia and Europe, covering all commercial and business aspects of products and companies. Michael Stafford has science and business (MBA) qualifications and has worked with some of the major players in the global pharmaceutical industry, including Pfizer, Glaxo SmithKline, Sanofi-Aventis, Merck-Serono and Biogen-Idec. He has particular experience in market assessment, buiness strategy, market access and reimbursement. As a senior executive at the peak industry body Medicines Australia, he analysed and contributed to over 300 submissions for reimbursement to the Australian government and represented industry in direct negotiations with the Government. He has developed the business plans for a number of companies to enter the Australian market and implemented the business plan for one company that successfully entered the market and achieved sales revenue of $10 million in the first year of operation.